Cochrane Abstracts
- I.4 Other
- I. Dilated cardiomyopathy
- Iatrogenic
- Iatrogenic Disease
- ICT
- Idarubicin
- Idiopathic recurrent vein thrombosis
- Idiopathic toe walking
- IgA nephropathy
- IgA paraproteinaemic demyelinating neuropathy
- IgG paraproteinaemic demyelinating neuropathy
- IgM paraproteinaemic demyelinating neuropathy
- Ileus
- Iliotibial Band Syndrome
- Iloprost
- Imaging, Three-Dimensional
- IMI Gold
- Imipramine
- - imiquimod
- - Imiquimod
- Immune System
- Immunization, Passive
- Immunizations
- Immunocompetence
- Immunocompromised Host
- Immunoglobulin E
- Immunoglobulin Fab Fragments
- Immunoglobulin treatment
- Immunomodulatory agents
- -immunomodulatory agents
- Immunostimulants
- Immunosuppressants (methotrexate, azathioprine, cyclophosphamide
- Immunosuppressive agents
- - immunosuppressive therapy (e.g. azathioprine, cyclosporin, cyclophosphamide)
- immunotherapy
- - immunotherapy
- Immunotherapy treatment
- Impacted teeth
- Impaired fetal growth and well-being
- Impetigo
- INBORN ERRORS OF METABOLISM IN GENERAL
- - incision and drainage
- Incision - types of
- Incontinence Pads
- Incubators, Infant
- Indians, North American
- Indirect Thrombin Inhibitors
- Individual patient data versus aggregate data from trialists
- Individual self-help
- Infant, Extremely Low Birth Weight
- Infant, Extremely Premature
- Infant, Very Low Birth Weight
- Infant Care
- Infant Formula
- Infant Mortality
- Infant Welfare
- Infectious disorders
- Inflammation
- Inflammatory Bowel Diseases
- Inflammatory disorders
- Inflammatory myopathy
- Inflammatory Myopathy
- Infliximab
- Information Dissemination
- Information provision and education
- Information provision to patients and caregivers
- Information-seeking initiated by the consumer, or information given by the consumer to the provider
- Infusions, Intra-Arterial
- Infusions, Parenteral
- Inhalant Abuse
- Injections, Intralesional
- Injections, Spinal
- Inlays
- Inositol
- Insect Bites and Stings
- Insecticides
- Insect Vectors
- Institutional settings
- Insulin-Like Growth Factor I
- Insulin-sensitizing agents
- Intellectual Disability
- - intensive care (toxic epidermal necrolysis)
- Interactive Health Communication Applications
- Interdental brushes/sticks
- interferon
- Interferon Inducers
- - interferon
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-2
- Intermittent pneumatic compression
- Intermittent Positive-Pressure Ventilation
- International Normalized Ratio
- Internet
- Interpersonal Relations
- Interprofessional Relations
- Interventions for fatigue
- Intestinal Neoplasms
- Intestinal Obstruction
- Intestinal Perforation
- Intra-articular injections
- Intracranial Aneurysm
- Intracranial Hypertension
- Intracranial venous thrombosis
- - intralesional bleomycin
- Intralesional steroids
- - intralesional treatments
- Intrauterine Devices, Copper
- INTRAVENOUS DELIVERY
- Intravenous immunoglobulin for prevention or treatment of proximal or multifocal diabetic neuropathy
- Intravenous immunoglobulin for treatment of dermatomyositis
- Intravenous immunoglobulin for treatment of polymyositis
- Intravenous immunoglobulin treatment (IVIg)
- - intravenous treatments
- Intussusception
- Invasive therapeutic procedures
- Invasive versus non-invasive ventilation
- Investigation
- Investigations
- 3-Iodobenzylguanidine
- Iron Chelating Agents
- Ischemic Preconditioning
- Isoflavones
- Isoniazid
- Isotonic Solutions